SEARCH

SEARCH BY CITATION

References

  • 1
    Tanagho EA, Schmidt RA. Bladder pacemaker: scientific basis and clinical future. Urology 1982; 20: 614619
  • 2
    van Voskuilen AC, Oerlemans DJ, Weil EH, de Bie RA, van Kerrebroeck PE. Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol 2006; 49: 366372
  • 3
    Amend B, Castro-Diaz D, Chartier-Kastler E et al. [Second-line therapy of idiopathic detrusor overactivity. Sacral neuromodulation and botulinum toxin A]. Urologe A 2010; 49: 245252
  • 4
    Hohenfellner M, Schultz-Lampel D, Dahms S, Matzel K, Thuroff JW. Bilateral chronic sacral neuromodulation for treatment of lower urinary tract dysfunction. J Urol 1998; 160: 821824
  • 5
    Powell CR, Kreder KJ. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol 2010; 183: 173176
  • 6
    Tjandra JJ, Chan MK, Yeh CH, Murray-Green C. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum 2008; 51: 494502
  • 7
    Baxter C, Kim JH. Contrasting the percutaneous nerve evaluation versus staged implantation in sacral neuromodulation. Curr Urol Rep 2010; 11: 310314
  • 8
    Kessler TM, Madersbacher H, Kiss G. Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method? Eur Urol 2005; 47: 660665
  • 9
    Spinelli M, Sievert KD. Latest technologic and surgical developments in using InterStim Therapy for sacral neuromodulation: impact on treatment success and safety. Eur Urol 2008; 54: 12871296
  • 10
    Kessler TM, Burkhard FC, Madersbacher H, Kofler A, Poewe W, Kiss G. Safety of prolonged sacral neuromodulation tined lead testing. Curr Med Res Opin 2008; 24: 343347
  • 11
    Huwyler M, Kiss G, Burkhard FC, Madersbacher H, Kessler TM. Microbiological tined-lead examination: does prolonged sacral neuromodulation testing induce infection? BJU Int 2009; 104: 646650; discussion 50
  • 12
    Sievert KD, Amend B, Gakis G et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol 2010; 67: 7484
  • 13
    Abrams P, Andersson KE, Birder L et al. 4th International Consultation on Incontinence. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. 2009
  • 14
    Peters KM, Killinger KA, Boura JA. Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation? Neurourol Urodyn 2011; 30: 14891492
  • 15
    White WM, Mobley JD 3rd, Doggweiler R, Dobmeyer-Dittrich C, Klein FA. Incidence and predictors of complications with sacral neuromodulation. Urology 2009; 73: 731735
  • 16
    Hijaz A, Vasavada SP, Daneshgari F, Frinjari H, Goldman H, Rackley R. Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology 2006; 68: 533537
  • 17
    El-Gazzaz G, Zutshi M, Salcedo L, Hammel J, Rackley R, Hull T. Sacral neuromodulation for the treatment of fecal incontinence and urinary incontinence in female patients: long-term follow-up. Int J Colorectal Dis 2009; 24: 13771381
  • 18
    Pannek J, Grigoleit U, Hinkel A. Bacterial contamination of test stimulation leads during percutaneous nerve stimulation. Urology 2005; 65: 10961098
  • 19
    Sievert KD, Nagele U, Pannek J, Engeler D, Kuczyk M, Stenzl A. Subcutaneous tunneling of the temporary testing electrode significantly improves the success rate of subchronic sacral nerve modulation (SNM). World J Urol 2007; 25: 607612
  • 20
    Aboseif SR, Kim DH, Rieder JM et al. Sacral neuromodulation: cost considerations and clinical benefits. Urology 2007; 70: 10691073; discussion 73–4
  • 21
    Daniels DH, Powell CR, Braasch MR, Kreder KJ. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction. Neurourol Urodyn 2010; 29: 578581
  • 22
    Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev 2004; 17: 863893, table of contents
  • 23
    Sariego J, Bootorabi B, Matsumoto T, Kerstein M. Major long-term complications in 1,422 permanent venous access devices. Am J Surg 1993; 165: 249251
  • 24
    Koolen DA, van Laarhoven HW, Wobbes T, Punt CJ. Single-centre experience with tunnelled central venous catheters in 150 cancer patients. Neth J Med 2002; 60: 397401
  • 25
    Bubeck J, Boos K, Krause H, Thies KC. Subcutaneous tunneling of caudal catheters reduces the rate of bacterial colonization to that of lumbar epidural catheters. Anesth Analg 2004; 99: 689693, table of contents